Assenagon Asset Management S.A. Pfizer Inc Transaction History

Assenagon Asset Management S.A.

$37.1 Billion
Q1 2024

A detailed history of Assenagon Asset Management S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 5,971,594 shares of PFE stock, worth $167 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

5,971,594

Previous 6,373,492 6.31%

Holding current value

$167 Million

Previous $183 Million 9.69%

% of portfolio

0.45%

Previous 0.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $10.4 Million - $11.9 Million	-401,898 Reduced 6.31%	5,971,594 $166 Million
Q4 2023 Jan 17, 2024	BUY	$26.13 - $33.94 $57.3 Million - $74.4 Million	2,191,326 Added 52.4%	6,373,492 $183 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $35.6 Million - $41.6 Million	1,107,971 Added 36.04%	4,182,166 $139 Million
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $137 Million - $159 Million	-3,799,004 Reduced 55.27%	3,074,195 $113 Million
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $145 Million - $189 Million	3,689,877 Added 115.91%	6,873,199 $280 Million

Q4 2022 Jan 12, 2023	SELL	$41.75 - $54.5 $385 Million - $502 Million	-9,217,842 Reduced 74.33%	3,183,322 $163 Million
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $456 Million - $557 Million	10,429,412 Added 528.94%	12,401,164 $543 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $122 Million - $145 Million	-2,628,162 Reduced 57.14%	1,971,752 $103 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $38.2 Million - $47.3 Million	834,467 Added 22.16%	4,599,914 $238 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $279,943 - $414,968	6,775 Added 0.18%	3,765,447 $222 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $18.5 Million - $23.7 Million	470,790 Added 14.32%	3,758,672 $162 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $118 Million - $134 Million	3,287,882 New	3,287,882 $129 Million
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $31.3 Million - $35.2 Million	-933,123 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $5.62 Million - $7.14 Million	167,813 Added 21.93%	933,123 $34.3 Million
Q3 2020 Oct 07, 2020	BUY	$31.75 - $37.25 $24.1 Million - $28.2 Million	758,193 Added 10653.27%	765,310 $28.1 Million
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $214,364 - $260,055	7,117 New	7,117 $233,000
Q1 2020 Apr 17, 2020	SELL	$27.03 - $38.62 $2.23 Million - $3.18 Million	-82,455 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $2.47 Million - $2.8 Million	74,955 Added 999.4%	82,455 $3.23 Million
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $107 Million - $138 Million	-3,280,065 Reduced 99.77%	7,500 $269,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $121 Million - $136 Million	3,267,565 Added 16337.83%	3,287,565 $142 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $64.2 Million - $70.5 Million	-1,711,328 Reduced 98.84%	20,000 $849,000
Q4 2018 Jan 23, 2019	SELL	$38.47 - $43.86 $17.3 Million - $19.7 Million	-449,273 Reduced 20.6%	1,731,328 $75.6 Million
Q3 2018 Oct 29, 2018	BUY	$34.47 - $41.81 $64.8 Million - $78.6 Million	1,879,142 Added 623.35%	2,180,601 $96.1 Million
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $10.9 Million - $11.6 Million	-331,278 Reduced 52.36%	301,459 $10.9 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $19.1 Million - $22.2 Million	600,096 Added 1838.47%	632,737 $22.5 Million
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $62.1 Million - $65.9 Million	-1,866,138 Reduced 98.28%	32,641 $1.18 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $58.9 Million - $64.8 Million	1,898,779	1,898,779 $67.8 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Pfizer Inc Transaction History